Branhamella catarrhalis has been suspected, on the basis of bacteriologic culture results, to have a pathogenic role in 6070-9070 of cases of acute otitis media as well as in other upper respiratory tract infections. Serologic evidence of this role was obtained with use of an enzyme immunoassay to detect antibodies to B. catarrhalis. The presence of both IgG and IgA antibodies to Branhamella in the serum and/or middle ear fluid (MEF) of children with acute otitis media correlated with the isolation of B. catarrhalis from cultures of their MEF. An increase in titer of antibodies to Branhamella between acutephase and convalescent-phase serum samples was found in 10 of the 19 children with otitis media from whom B. catarrhalis but no other pathogen was isolated from the MEF. Such an increase was found in none of the 14 children with otitis media caused by other organisms.
Branhamella catarrhalis (previously called Neisseria catarrhalis) is a common saprophytic organism in the upper respiratory tract. Recently it has been suggested to have pathogenic properties as well. For example, it has been implicated as a cause of acute bronchitic episodes in patients with chronic respiratory disease [1] and in some cases of acute maxillary sinusitis [2] . It was the only pathogen isolated from the middle ear fluid (MEF) in 60/0-90/0 of cases of acute otitis media in children in several studies [3] [4] [5] [6] [7] . In a recent study [8] , B. catarrhalis was the only pathogen cultured from the MEF of 6% of patients with acute otitis media. Gram-stained smears of MEF samples from these patients revealed polymorphonuclear leukocytes in 90% and gram-negative diplococci in 50%. The latter often appeared intracellularly in the polymorphonuclear leukocytes. MEF samples from which B. catarrhalis was cultured were indistinguishable from MEF samples from which Streptococcus pneumoniae was cultured in both percentage of polymorphonuclear leukocytes and general cytologic appearance. These findings suggest that B. catarrhalis is a true pathogen in these cases of acute otitis media.
We reasoned that a true pathogen was likely to provoke an immune response, the demonstration of which would give further support to its pathogenic role. For this purpose, we developed an assay to detect antibodies to B. catarrhalis. The present study reports evidence of an antibody response in those patients with acute otitis media whose MEF culture results had implicated B. catarrhalis as the etiologic agent.
Materials and Methods
Patients. The subjects of the present study were selected from a group of 519 children with acute otitis media who visited the Departments of Otolaryngology and Pediatrics at the University Central Hospital of Oulu, Oulu, Finland, between October 1977 and December 1978 [8] . A child was considered to have acute otitis media if acute ear and/or upper respiratory tract symptoms were present and fluid could be aspirated by tympanocentesis from behind an inflamed eardrum. Patients who received antibiotics at the time of the visit or within the previous week or who had had an episode of otitis during the previous month were excluded from the study. One-fourth of the children had never had acute otitis media before the index episode, and well over one-half had experienced three or more episodes. Bacteriologic culture of the MEF yielded S. pneumoniae from 39% of the patients, Haemophilus influenzae from 12%, B. catarrhalis from 6%, Streptococcus pyogenes from 2%, Staphylococcus aureus from 5%, and Staphylococcus epidermidis from 14% * Presence ( +) or absence ( -) of antibody activity in the enzyme immunoassay with Branhamella antigen. (mainly those younger than two years of age), whereas 33070 had negative cultures. We did not look for virus, Chlamydia, and Mycoplasma.
Three groups of children were chosen for the present study. The main study group consisted of all 19 patients from whose MEF B. catarrhalis had been cultured either alone or, in two cases, with S. epidermidis and from whom a blood sample had been drawn both in the acute stage of the disease and two to three weeks later. The age distribution (figure 1) of these 19 children was similar to that of all 519 children. In four children, all five to 12 months old, this episode was the first episode of otitis media, whereas nine had had three or more previous episodes. Of the 11 children considered to have bilateral otitis media, culture of MEF from the other ear was negative for seven children, whereas it yielded B. catarrhalis from three and S. 2) against serial dilutions of sera from rabbits immunized with this antigen. A dilution of 1:250 gave the highest IgG antibody titer (1:5,260) in the hyperimmune sera but a low OD (about 0.2) in preimmunization sera and in sera from rabbits immunized with H. influenzae. Antigen (150 /-II) at this dilution was placed in each well, and the plates were incubated at 37 C for 5 hr before being washed three times with PBS containing 0.05070 Tween 20 (PBS-Tween), pH 7.2. All serum samples were diluted in 4% PBSTween, starting with a dilution of 1:50 (if this dilution gave a negative result, no further dilutions were tested). The plates were incubated with 150/-11 in each well of the serum dilutions for 1 hr at 37 C and washed with 0.05% PBS-Tween three times. Alkaline phophatase-conjugated swine antibodies to rabbit IgG or antibodies to human IgG, IgA, and IgM (Orion Diagnostica, Helsinki, Finland) were diluted to 1:300, 1:400, 1:300, and 1:250, respectively, in 4% PBS-Tween. The conjugate dilutions (150 /-II) were added to the wells and incubated at 37 C for 2 hr, after which the plates were washed with 0.05% PBS-Tween three times. Substrate solution (150 /-II) (1 mg of p-nitrophenyl phosphate [Sigma Chemical Co., St. Louis, Mo.]) in 1 M diethanolamine buffer containing 2 mmol of MgClz, pH 9.8), was added and incubated at 37 C for 30 min. The reaction was stopped by adding 50 /-II of a solution of 2 N NaOH. ODs were measured at 405 nm with a multichannel photometer (Titertek Multiskan"; Eflab, Helsinki, Finland). Each assay was performed in triplicate; the results are given as reciprocal serum dilutions giving an OD of 0.5 in the enzyme immunoassay [9] .
Results
Antibodies to Branhamella in patient sera. Relatively high reciprocal titers (up to 1, 000) were seen in these sera, and both the presence and the level of antibodies to Branhamella depended on the age of the child. No such antibodies were seen in children younger than 10 months of age. In the three children 10-12 months old, IgG antibodies to Branhamella were undetectable in the acutephase sera but reached reciprocal titers of in the convalescent-phase sera. In children older than one year, IgG antibodies to Branhamella were detected in acute-phase sera. In all of the children with IgG antibodies to Branhamella there was a change in the titer between the two serum samples; in nine children there was an increase, in five a decrease, in the titer.
IgA antibodies to Branhamella appeared at a somewhat later age. They were not found in the sera of any of the 10 children younger than two years of age but were present in eight of the nine children two to six years old. The reciprocal IgA antibody titers were lower (all <300) than the corresponding IgG antibody titers, and, like the IgG antibody titers, either increased or decreased in the acute-phase serum sample relative to the convalescent-phase serum sample. No IgM antibodies to Branhamella were detected in the sera studied.
In paired sera from children who had otitis media caused by bacteria other than Branhamella (figure 1, bottom), IgM and IgA antibodies to Branhamella were not found. IgG antibodies to Branhamella were present in seven of these 14 children and more often in older children. There were, however, no changes in the IgG antibody titer between the acute-and convalescent-phase sera, and the overall levels were lower (all reciprocals <400) than in the children who had otitis media from whose MEF B. catarrhalis was isolated.
We also looked for antibodies to Branhamella in MEF samples from which B. catarrhalis had been isolated (table 1) . Antibody levels in these MEF samples could not be quantitated because the dilutions of the samples varied; for collection, the amount of fluid obtained from one ear was mixed with 1 ml of saline. The data in table 1 do show that both IgG and IgA antibodies were present in most of the MEF samples (eight of 11), but again IgM antibodies were not detected. IgG antibodies were regularly present in the MEF (as well as in the serum) of children older than one year of age and were occasionally found in the MEF of children as young as five months of age (at which age serum antibody levels were very low). IgA antibodies were detected in the MEF of all six children older than 10 months of age and in the MEF of one eight-month-old child. The corresponding serum sample was negative for IgA antibodies in three of these infants (aged eight, 11, and 13 months). Thus, both classes of antibodies to Branhamella were detected in the MEF a little earlier than in the serum, a difference suggesting local antibody production in the middle ear. [2] found precipitating antibodies to Branhamella in sera from patients with maxillary sinusitis for whom cultures had revealed no other pathogen. They also found such antibodies in the sera of healthy blood donors. However, they detected CF antibodies and recorded a change in the titers of the patients but not in the titers of the healthy blood donors. Lewis et al. [10] have demonstrated that IgG antibodies to Neisseria (possibly B. catarrha/is) were present during serous otitis media, both in the serum and in the ear effusion from which the same bacteria were also isolated.
In the present study we found IgG antibodies, but not IgA or IgM antibodies, to Branhamella in our control sera, obtained from children who had otitis media caused by pathogens other than B. catarrhalis (mainly pneumococci and H. inf/uenzae). Both the frequency and the titers of these antibodies increased with the age of the child. No differences in IgG antibody titers were, however, seen between acute-and convalescent-phase sera. These findings are very similar to those of Brorson et al. [2] . It is probable that the presence of these antibodies indicates continuous immunogenic stimulation by B. catarrhalis organisms which are regularly present in the normal micro flora of the upper respiratory tract. However, some of the children may have previously had B. catarrhalis infections -primarily otitis media -because most of the patients in this study had had several episodes of otitis media. Nevertheless, the constancy of the antibody titers and the absence of IgA anti-573 bodies to Branhamella mean that an acute infection with an immune response to B. catarrhalis is unlikely.
The titers of IgG antibodies to Branhamella were, as a rule, higher in the children whose MEF cultures grew B. catarrhalis than in the control children of the same age ( figure 1) . Either an increase or decrease in these titers was regularly recorded between the acute-and convalescent-phase sera, a difference which suggests an ongoing immune response to B. catarrhalis in the ear. Furthermore, the presence of IgA antibodies to Branhamella indicates a recent stimulus because IgA has a short t Yz and was absent in the control children.
The decreasing antibody titers in some of the children could not be related to any observed parameter, such as age or the number of previous episodes of otitis media. However, it is reasonable to suppose that B. catarrhalis had been present in these children and had caused milder -unnoticed or unrecorded -upper respiratory tract infections before the eruption of otitis media. To determine whether this proposal is the correct explanation requires closer serologic follow-up of children with mild upper respiratory tract infections.
We do not know why IgM antibodies to Branhamella were not detected in any of the sera or MEF samples studied. This absence could indicate that the enzyme immunoassay is unable to detect these antibodies. However, we have easily detected IgM antibodies to several other antigens by similar enzyme immunoassays using the same conjugate of alkaline phosphatase and antibody to IgM [9] . We therefore consider it more likely that this antibody class is not part of the immune response to B. catarrha/is in the upper respiratory tract. To understand the reason for this lack of activity, it would be necessary to know to which antigens (lipopolysaccharide or protein) the measured antibodies are directed. A comparable enzyme immunoassay for antibodies to Yersinia enteroco/itica primarily measured antibodies to the lipopolysaccharide (11] .
The evidence we have for a pathogenic role of B. catarrhalis in acute otitis media is threefold. (1) The organism is often isolated from MEF in pure culture. In addition, it is often isolated with other bacteria such as pneumococci, H. inf/uenzae, or S. epidermidis at the same low frequency as mixed infections or contaminants are found [8] . (2) The recognition of B. catarrhalis as a pathogen in otitis media is important because f3-lactamase is often found in clinical isolates [12] [13] [14] . {3-Lactamase inactivates penicillin and ampicillinamoxicillin, making them ineffective treatment regimens. In Finland 200/0 of B. catarrhalis strains isolated from the MEF of patients with otitis media presently produce f3-lactamase, whereas all strains are sensitive to the common alternative regimens, erythromycin or sulfonamide-trimethoprim (authors' unpublished observation). In Finland B. catarrhalis is the third most commonly encountered pathogen in the MEF, after only pneumococci and H. influenzae, which is also a potential f3-lactamase producer.
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